Cambridge Cancer Genomics alternatives
TL;DR: 12 companies doing similar work to Cambridge Cancer Genomics in Healthcare, ranked by how closely they match what Cambridge Cancer Genomics actually does — not just by category.
How this list was built: every company here is Y Combinator-backed and shares at least one category with Cambridge Cancer Genomics. They are scored on how closely their own description overlaps with Cambridge Cancer Genomics's, and all facts shown come from the YC company records — nothing is estimated.
What are the best alternatives to Cambridge Cancer Genomics?
| Alternative | What it does | Batch | Team | Status |
|---|---|---|---|---|
| Data Driven Bioscience | Cancer Diagnosis 10X faster, 10X cheaper | Summer 2018 | 10 | Active |
| Kenota (formerly ExVivo Labs) | Kenota is revolutionizing the way we test for disease | Summer 2016 | 35 | Inactive |
| Clear Gene | Our tests help eradicate cancer by telling doctors whether they got… | Summer 2018 | 4 | Active |
| Numen | Engineering a future without cancer deaths. | Summer 2023 | 18 | Active |
| LSK Technologies | A diagnostic lab in a box | Summer 2020 | 2 | Acquired |
| Moichor | AI Powered Animal Diagnostics | Winter 2021 | 29 | Active |
| Radix Labs | Operating systems for biology labs | Summer 2018 | 7 | Inactive |
| Atlas Discovery | AI-native pharma company | Summer 2026 | 3 | Active |
| Eden | Building Clinical Superintelligence. | Summer 2018 | 100 | Active |
| Oncobox | Finding the right cancer drug for each patient. | Summer 2017 | 11 | Active |
| Zergo | We make a urine test that helps women get pregnant. | Summer 2019 | 9 | Inactive |
| Instapath Inc. | We built the world's first automated digital pathology lab. | Winter 2019 | 6 | Active |
Is Cambridge Cancer Genomics still active?
Cambridge Cancer Genomics is no longer listed as active, so anyone still relying on it should plan a migration to one of the alternatives above.
How was this list put together?
Every company here is Y Combinator-backed and shares at least one category with Cambridge Cancer Genomics. They are then ranked on how closely their own description overlaps with Cambridge Cancer Genomics's, so the closest matches come first rather than whoever happens to share a tag.